Insiders · Profile

Barrow Robert

Chief Executive Officer at Definium Therapeutics. Filing since 25 May 2022. CIK 0001897557

Company

Date

Role

Action

Shares

Amount

Of holding

DFTX Definium Therapeutics, Inc.

25 Sep 2026

Chief Executive Officer

Sold on a plan

31,550

$1.15M

1.4%

DFTX Definium Therapeutics, Inc.

3 Sep 2026

Chief Executive Officer

Sold on a plan

19,023

$721.73K

1.3%

DFTX Definium Therapeutics, Inc.

25 Jun 2026

Chief Executive Officer

Sold on a plan

29,208

$1.32M

2.6%

DFTX Definium Therapeutics, Inc.

25 Mar 2026

Chief Executive Officer

Sold on a plan

24,431

$451.24K

3.1%

DFTX Definium Therapeutics, Inc.

26 Dec 2025

Chief Executive Officer

Sold on a plan

25,791

$339.07K

3.2%

DFTX Definium Therapeutics, Inc.

25 Sep 2025

Chief Executive Officer

Sold on a plan

25,797

$252.04K

3.1%

DFTX Definium Therapeutics, Inc.

25 Jun 2025

Chief Executive Officer

Sold on a plan

26,491

$180.14K

3.1%

DFTX Definium Therapeutics, Inc.

25 Mar 2025

Chief Executive Officer

Sold on a plan

21,208

$142.94K

2.4%

DFTX Definium Therapeutics, Inc.

26 Dec 2024

Chief Executive Officer

Sold on a plan

19,106

$141.96K

3.5%

DFTX Definium Therapeutics, Inc.

25 Sep 2024

Chief Executive Officer

Sold on a plan

19,771

$118.23K

3.5%

DFTX Definium Therapeutics, Inc.

20 Aug 2024

Chief Executive Officer

Bought

500

$3.06K

0.1%

DFTX Definium Therapeutics, Inc.

19 Aug 2024

Chief Executive Officer

Bought

500

$3.16K

0.1%

DFTX Definium Therapeutics, Inc.

25 Jun 2024

Chief Executive Officer

Sold on a plan

15,659

$113.06K

2.7%

DFTX Definium Therapeutics, Inc.

25 Mar 2024

Chief Executive Officer

Sold on a plan

16,519

$156.93K

2.8%

DFTX Definium Therapeutics, Inc.

26 Dec 2023

Chief Executive Officer

Sold at will

13,237

$48.05K

2.2%

DFTX Definium Therapeutics, Inc.

25 Sep 2023

Chief Executive Officer

Sold at will

13,499

$48.27K

2.2%

DFTX Definium Therapeutics, Inc.

27 Jun 2023

Chief Executive Officer

Sold at will

15,502

$49.62K

2.4%

DFTX Definium Therapeutics, Inc.

1 Mar 2023

Chief Executive Officer

Sold, plan not stated

8,273

$29.04K

3.3%

DFTX Definium Therapeutics, Inc.

21 Dec 2022

Chief Executive Officer

Sold, plan not stated

3,861

$10.39K

1.5%

DFTX Definium Therapeutics, Inc.

25 Oct 2022

Chief Executive Officer

Sold, plan not stated

1,207

$3.39K

0.5%

DFTX Definium Therapeutics, Inc.

18 Oct 2022

Chief Executive Officer

Sold, plan not stated

1,220

$3.79K

0.5%

DFTX Definium Therapeutics, Inc.

26 Sep 2022

Chief Executive Officer

Sold, plan not stated

1,264

$6.96K

0.5%

DFTX Definium Therapeutics, Inc.

16 Sep 2022

Chief Executive Officer

Sold, plan not stated

1,350

$9.80K

0.5%

DFTX Definium Therapeutics, Inc.

31 Aug 2022

Chief Executive Officer

Sold, plan not stated

1,228

$14.33K

0.5%

DFTX Definium Therapeutics, Inc.

16 Aug 2022

Chief Executive Officer

Sold, plan not stated

20,350

$13.84K

0.5%

DFTX Definium Therapeutics, Inc.

25 Jul 2022

Chief Executive Officer

Sold, plan not stated

18,681

$12.89K

0.5%

DFTX Definium Therapeutics, Inc.

18 Jul 2022

Chief Executive Officer

Sold, plan not stated

19,388

$13.57K

0.5%

DFTX Definium Therapeutics, Inc.

27 Jun 2022

Chief Executive Officer

Sold, plan not stated

36,762

$25.73K

0.9%

DFTX Definium Therapeutics, Inc.

16 Jun 2022

Chief Executive Officer

Sold, plan not stated

21,275

$14.89K

0.5%

DFTX Definium Therapeutics, Inc.

25 May 2022

Chief Executive Officer

Sold, plan not stated

18,415

$14.18K

0.5%

30 decisions on file.